(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.Based on the information reviewed, the reported patient effect of vessel perforation appears to be related to procedural conditions and was likely caused by insertion of the steerable guide catheter(sgc).The reported hemorrhage appears to be a secondary effect of the perforation.The reported patient effects of vessel perforation or laceration and bleeding/hemorrhage, as listed in the mitraclip system instructions for use are known possible complications associated with mitraclip procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
This is filed to report the perforation.It was reported that this was a mitraclip procedure to treat degenerative mitral regurgitation (mr) with an mr grade of 3-4.The steerable guide catheter (sgc) was inserted without issue, the clip delivery system (cds)was advanced successfully and one clip was implanted, reducing mr to <1.After the procedure, when the devices were removed, hemostasis of the femoral access failed.Contra femoral artery access was obtained and balloon angioplasty balloon was performed to treat the perforated right femoral artery.The artery was surgically closed.The procedure was prolonged two hours due to the arteriotomy.It is the physicians opinion that the perforation was caused by the sgc.The patient is stable.No additional information was provided.
|